Accessibility Menu
First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF logo

First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF(NASDAQ) FTXH

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2016)+116%
5 Year+56%
1 Year+50%
1 Month-0%
$39.36
+0.94%
+0.36Today
First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF last closing stock price
MetricPriceDate
Last closeUSD 39.002026-08-04
First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.74%USD 39.692026-07-28
1 month-0.38%USD 39.152026-07-02
3 month+13%USD 34.512026-05-06
Year to date+18.88%USD 32.802025-12-31
1 year+49.56%USD 26.072025-08-04
3 year+55.85%USD 25.022023-08-04
5 year+56.02%USD 24.992021-08-05
Since inception+116.24%USD 18.032016-09-22

First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.42

Beta (Volatility)

0.54 (Low)

Price

$39.36

Volume

26,750.199

Open

$39.59

Previous Close

$39.00

Daily Range

$39.36 - $39.75

52-Week Range

$26.00 - $42.87

Estimated Earnings Date

N/A

FTXH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF operates as an exchange-traded fund focused on mirroring the financial performance of the Nasdaq US Smart Pharmaceuticals Index. This ETF aims for a performance correlation of at least 95%, providing investors with exposure to the pharmaceutical sector.

Products and Services
  • Exchange-traded fund focused on pharmaceuticals
  • Investment strategy aimed at capital appreciation and income generation
  • Replicates constituents of the Nasdaq US Smart Pharmaceuticals Index
Growth Outlook
  • Market capitalization stands at approximately $36.69 million
  • Recent stock price range between $25.765 and $39.57
  • Dividend yield of 1.10% reflects steady income potential
Financial Highlights
  • Recent trading volume averages around 9,051 shares
  • Quarterly dividend paid of $0.424 per share
  • Beta of 0.45 indicates lower volatility compared to the market
The First Trust Nasdaq Pharmaceuticals ETF provides a strategic investment opportunity for those interested in the pharmaceutical sector. With a focus on replicating the performance of a specialized index, this ETF offers potential for both capital appreciation and income generation. The recent stock price movements and dividend yield suggest a stable investment option within the asset management industry.
AI Generated • Jul 21, 2026

Industry

Capital Markets

Sector

Financials

Headquarters

Wheaton, IL 60187, US

FTXH Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

1.09%

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

23.65M

Volume

26.75K

Avg. Volume

560.49K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FTXGFirst Trust Nasdaq Food & Beverage ETF
$22.87-0.15%
RNEMFirst Trust Emerging Markets Equity Select ETF
$57.39-0.09%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$115.61-0.08%
NVDANvidia
$220.18+0.04%
YXTYxt.com Group
$7.76+1.98%
INLFInlif
$6.01+0.89%

Questions About FTXH

What is the current price of First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF?

First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF is trading at $39.54 per share.

What is the 52-week range for First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF?

Over the past 52 weeks, First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF has traded between $26.00 and $42.87.

How much debt does First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF have?

First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF total debt is unavailable.

How much cash does First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF have on hand?

First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF does not have cash on hand data available.

What is First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF’s dividend yield?

First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF currently has a dividend yield of 1.09%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services